This finding, together with a clinical finding that suggested the positive correlation of NLRP3 expression with advanced disease and poor prognosis in patients with CRC, indicates the potential relevance of NLRP3 inflammasome as a therapeutic target [117]. Here, NLRP3 is linked to colorectal carcinoma.